The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

GRAZAX standardised allergen extract of grass pollen from Timothy grass (Phleum pratense) 75,000 SQ-T sublingual tablets blister foil (267955)

ARTG ID 267955

ARTG Name

GRAZAX standardised allergen extract of grass pollen from Timothy grass (Phleum pratense) 75,000 SQ-T sublingual tablets blister foil

Product name

GRAZAX standardised allergen extract of grass pollen from Timothy grass (Phleum pratense) 75,000 SQ-T sublingual tablets blister foil

ARTG Date

7 March 2017

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

Phleum pratense

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

GRAZAX standardised allergen extract of grass pollen from Timothy grass (Phleum pratense) 75,000 SQ-T oral lyophilisate tablets blister foil, Seqirus Pty Ltd, CON-356

29 January 2020

Section 14 consent

Consent to while noncompliant with standards. The consent is effective from the 29 January 2020 until 1 March 2022.
GRAZAX standardised allergen extract of grass pollen from Timothy grass (Phleum pratense) 75,000 SQ-T sublingual tablets blister foil, Seqirus Pty Ltd, CON-906

31 January 2022

Section 14 consent

Consent to while noncompliant with standards. The consent is effective from 31 January 2022 until 1 March 2024.